Page 164 - The Memory Program How to Prevent Memory Loss and Enhance Memory Power
P. 164

Page 153

                Stimulation of superoxide dismutase, a powerful naturally occurring enzyme in the body that
                 also destroys free radicals.
                This dual antioxidant action likely underlies selegiline's action in delaying functional decline in
                 Alzheimer's disease.
                Giving selegiline to mice leads to a higher density of nerve fibers in the frontal cortex and
                 hippocampus.
                Mice given selegiline at about twenty-four months of age can increase, even double, their life
                 expectancy beyond that point. In those studies, the mice demonstrated improved intelligence,
                 measured by the ability to negotiate complex mazes and to develop a strategy to escape from
                 water tanks. Experiments in dogs showed similar, but less robust, effects.


              Obviously, taking selegiline will not double your life span as it can in mice, but its broad antiaging
            effects are a plus. Overall, the weight of the evidence suggests that it may be useful in preventing
            age-related memory loss.

            Taking Selegiline to Prevent Memory Loss


            Selegiline can cause insomnia, so it should be taken in the morning as a single daily dose. The usual
            dose range is 5 to 15 mg daily, though it can be given up to 60 mg per day to healthy people without
            any major side effects. Selegiline's action in inhibiting monoamine oxidase-B can make it toxic, but
            only in very high doses. Some physicians themselves use selegiline as an antiaging treatment.
            However, even among this group of people who can easily obtain medications, vitamin E is more
            popular. I have included selegiline as a second-level option in the Memory Program. Unlike vitamin
            E, selegiline is a prescription medication.

            Vitamin E and Selegiline (Deprenyl)


            My colleague Dr. Mary Sano headed a national consortium that compared four treatment conditions:
            vitamin E, selegiline (also called Deprenyl), vitamin E plus selegiline, and placebo to treat three
            hundred outpatients with early to midstage Alzheimer's disease. They found that both vitamin E
            2,000 IUs daily (a high dose) and selegiline helped delay functional deterioration or nursing home
            placement by six months to a year. The results were published in the New England Journal of
            Medicine in 1997. Vitamin E alone, selegiline alone, and the combination of vitamin E and selegiline
            each delayed
   159   160   161   162   163   164   165   166   167   168   169